The GSTZ1 Knockout SK-HEP-1 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human hepatic adenocarcinoma cell line SK-HEP-1, featuring targeted disruption of the GSTZ1 gene. This polyclonal population serves as a heterogeneous loss-of-function model, enabling researchers to interrogate the multifaceted roles of glutathione S-transferase zeta 1 (GSTZ1) in tyrosine catabolism, xenobiotic detoxification, and redox homeostasis without clonal selection bias. The polyclonal format provides a collective phenotypic representation that is particularly valuable for pathway analysis and population-level functional studies.
The host cell line, SK-HEP-1, was originally isolated from ascitic fluid of a patient with liver adenocarcinoma and is characterized by a unique endothelial-like phenotype, including expression of adhesion molecule CD31 and von Willebrand factor. This dual epithelial-endothelial identity makes SK-HEP-1 a widely adopted model for studying hepatic sinusoidal endothelium, angiogenesis, and metabolic functions. Its stable growth characteristics and well-documented molecular profile render it an ideal substrate for CRISPR-mediated gene editing, allowing dissection of gene function in a relevant hepatic context with vascular implications.
GSTZ1 is a bifunctional enzyme that occupies a critical node in the tyrosine degradation pathway, catalyzing the glutathione-dependent isomerization of maleylacetoacetate to fumarylacetoacetate downstream of TAT, HPD, and HGD, and upstream of FAH, which cleaves fumarylacetoacetate. Beyond its role in amino acid catabolism, GSTZ1 functions as a dichloroacetate dehalogenase, mediating detoxification of this xenobiotic. Its expression is transcriptionally regulated by stress-responsive factors NRF2, AhR, and HIF1A, and its catalytic activity requires glutathione as a cofactor, with the enzyme assembling into homodimers. This integration of metabolic and detoxification functions positions GSTZ1 as a key regulator of cellular resilience.
In the SK-HEP-1 background, ablation of GSTZ1 disrupts the canonical tyrosine degradation cascade, potentially leading to accumulation of maleylacetoacetate and perturbed glutathione homeostasis, which may sensitize cells to oxidative stress and alter responses to dichloroacetate exposure. Given the endothelial-like features of SK-HEP-1, the knockout model offers a unique platform to explore the intersection between hepatic metabolism, redox signaling, and endothelial cell behavior, including angiogenesis and barrier function, thereby revealing previously unrecognized roles of GSTZ1 in liver pathophysiology.
This knockout cell population is ideally suited for a broad range of experimental applications, including investigation of tyrosine catabolism defects analogous to tyrosinemia, pharmacogenomic studies of dichloroacetate toxicity, and dissection of glutathione-dependent detoxification mechanisms. Researchers can employ functional assays such as measurement of GSTZ1 activity with maleylacetoacetate, western blotting, RT-qPCR quantification, targeted metabolite profiling by LC-MS, glutathione conjugation assays, and cellular proliferation assays under dichloroacetate challenge. For further technical details or assistance, please contact Ascent Research.
